175 related articles for article (PubMed ID: 11526391)
1. Tolerogenic strategies to halt or prevent type 1 diabetes.
Cooke A; Phillips JM; Parish NM
Nat Immunol; 2001 Sep; 2(9):810-5. PubMed ID: 11526391
[TBL] [Abstract][Full Text] [Related]
2. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER
Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846
[TBL] [Abstract][Full Text] [Related]
3. beta-Cell death during progression to diabetes.
Mathis D; Vence L; Benoist C
Nature; 2001 Dec; 414(6865):792-8. PubMed ID: 11742411
[TBL] [Abstract][Full Text] [Related]
4. Gene- and cell-based therapeutics for type I diabetes mellitus.
Bottino R; Lemarchand P; Trucco M; Giannoukakis N
Gene Ther; 2003 May; 10(10):875-89. PubMed ID: 12732873
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice.
Verda L; Kim DA; Ikehara S; Statkute L; Bronesky D; Petrenko Y; Oyama Y; He X; Link C; Vahanian NN; Burt RK
Stem Cells; 2008 Feb; 26(2):381-6. PubMed ID: 17975228
[TBL] [Abstract][Full Text] [Related]
6. New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes.
Zhao Y; Lin B; Dingeldein M; Guo C; Hwang D; Holterman MJ
Transl Res; 2010 May; 155(5):211-6. PubMed ID: 20403575
[TBL] [Abstract][Full Text] [Related]
7. Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution.
Nishio J; Gaglia JL; Turvey SE; Campbell C; Benoist C; Mathis D
Science; 2006 Mar; 311(5768):1775-8. PubMed ID: 16556845
[TBL] [Abstract][Full Text] [Related]
8. Does autoantigen administration inhibit recurrence of type 1 diabetes in transplanted islets?
Mojtahedi Z; Farjadian S; Ghaderi A
Med Hypotheses; 2005; 64(5):986-8. PubMed ID: 15780496
[TBL] [Abstract][Full Text] [Related]
9. The role of low avidity T cells in the protection against type 1 diabetes: a modeling investigation.
Khadra A; Santamaria P; Edelstein-Keshet L
J Theor Biol; 2009 Jan; 256(1):126-41. PubMed ID: 18950644
[TBL] [Abstract][Full Text] [Related]
10. Islet replacement vs. regeneration: hope or hype?
Ramiya V; Schatz D
Pediatr Diabetes; 2004; 5 Suppl 2():45-56. PubMed ID: 15601374
[TBL] [Abstract][Full Text] [Related]
11. Patients with chronic pancreatitis have islet progenitor cells in their ducts, but reversal of overt diabetes in NOD mice by anti-CD3 shows no evidence for islet regeneration.
Phillips JM; O'Reilly L; Bland C; Foulis AK; Cooke A
Diabetes; 2007 Mar; 56(3):634-40. PubMed ID: 17327430
[TBL] [Abstract][Full Text] [Related]
12. Of mice and men: use of animal models to identify possible interventions for the prevention of autoimmune type 1 diabetes in humans.
Serreze DV; Chen YG
Trends Immunol; 2005 Nov; 26(11):603-7. PubMed ID: 16140038
[TBL] [Abstract][Full Text] [Related]
13. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD20 treatment prolongs syngeneic islet graft survival and delays the onset of recurrent autoimmune diabetes.
Hu C; Deng S; Wong FS; Wen L
Ann N Y Acad Sci; 2008 Dec; 1150():217-9. PubMed ID: 19120299
[TBL] [Abstract][Full Text] [Related]
15. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
Yang Y; Santamaria P
J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740
[No Abstract] [Full Text] [Related]
16. Autoreactive T cells in endocrine/organ-specific autoimmunity: why has progress been so slow?
Roep BO
Springer Semin Immunopathol; 2002 Dec; 24(3):261-71. PubMed ID: 12503054
[TBL] [Abstract][Full Text] [Related]
17. Maintaining or breaking CD8+ T-cell tolerance to beta islet cell antigens: lessons from transgenic mouse models.
Piaggio E; Hartemann-Heurtier A; Cabarrocas J; Desbois S; Mars LT; Zappulla JP; Liblau RS
J Autoimmun; 2004 Mar; 22(2):115-20. PubMed ID: 14987739
[No Abstract] [Full Text] [Related]
18. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression.
Kobayashi T; Aomatsu Y; Iwata H; Kin T; Kanehiro H; Hisanaga M; Ko S; Nagao M; Nakajima Y
Transplantation; 2003 Mar; 75(5):619-25. PubMed ID: 12640299
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha impairs peripheral tolerance towards beta-cells, and local costimulation by B7.1 enhances the effector function of diabetogenic T cells.
Skak K; Guerder S; Picarella DE; Brenden N; Flavell RA; Michelsen BK
Eur J Immunol; 2003 May; 33(5):1341-50. PubMed ID: 12731060
[TBL] [Abstract][Full Text] [Related]
20. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes.
Ogawa N; Minamimura K; Kodaka T; Maki T
J Autoimmun; 2006 Jun; 26(4):225-31. PubMed ID: 16713179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
